ORMP - Oramed Pharmaceuticals Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (May 2020)Next Qtr. (Aug 2020)Current Year (2020)Next Year (2021)
No. of Analysts3333
Avg. Estimate-0.14-0.12-0.63-0.72
Low Estimate-0.16-0.18-0.79-0.91
High Estimate-0.11-0.03-0.51-0.59
Year Ago EPS-0.23-0.13-0.82-0.63
Revenue EstimateCurrent Qtr. (May 2020)Next Qtr. (Aug 2020)Current Year (2020)Next Year (2021)
No. of Analysts3333
Avg. Estimate450k1.45M3.04M2.92M
Low EstimateN/AN/A700kN/A
High Estimate700k3.65M5.62M5.95M
Year Ago SalesN/A681k2.7M3.04M
Sales Growth (year/est)N/A112.90%12.50%-3.90%
Earnings History5/30/20198/30/201911/29/20192/28/2020
EPS Est.-0.23-0.24-0.24-0.17
EPS Actual-0.23-0.13-0.15-0.21
Difference00.110.09-0.04
Surprise %0.00%45.80%37.50%-23.50%
EPS TrendCurrent Qtr. (May 2020)Next Qtr. (Aug 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.14-0.12-0.63-0.72
7 Days Ago-0.14-0.12-0.63-0.72
30 Days Ago-0.15-0.08-0.69-0.72
60 Days Ago-0.2-0.13-0.82-0.78
90 Days Ago-0.2-0.13-0.85-0.79
EPS RevisionsCurrent Qtr. (May 2020)Next Qtr. (Aug 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesORMPIndustrySectorS&P 500
Current Qtr.39.10%N/AN/A-0.34
Next Qtr.7.70%N/AN/A-0.12
Current Year23.20%N/AN/A-0.18
Next Year-14.30%N/AN/A0.26
Next 5 Years (per annum)N/AN/AN/A0.04
Past 5 Years (per annum)N/AN/AN/AN/A